Commercial and Portfolio Analysis

Objective:

Develop a combined vaccine and biosimilar strategy for a start-up drug company.

Activities:

  • Identify pipeline candidates
  • Research a marketing and reimbursement strategy
  • Support the development of an initial regulatory strategy
  • Initiated discussions for the in-licensing of molecules

Deliverables:

  • Various financial models
  • A manufacturing strategy
  • A marketing and reimbursement strategy

Result:

A recommendation that the in-licensing models proposed along with the unique market and reimbursement dynamics made the business a higher risk than client originally anticipated.  Client elected not to pursue the model further.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.